Finally, the synaptic protein neurexin-1 (NRXN1), a potential biomarker of neurodegeneration in Alzheimer’s disease, was found to be consistently decreased after TBI compared to control (Fig. 3K). The gene discussed is NRXN1; the disease is Alzheimer disease.